About Konovo
Konovo is a healthcare-focused market research company headquartered in the United States, launched in April 2025 as a unified brand bringing together three established healthcare research firms: InCrowd, Survey Healthcare Global (SHG), and GlocalMind. The company is a Frazier Healthcare Partners portfolio company.
Konovo positions itself as an AI-native, intelligent research platform, aiming to simplify and speed up healthcare market research by combining the reach and expertise of its three founding brands. The platform supports AI-assisted survey design, agile research methods, and integrates real-time research with longer-form studies, connecting market research agencies, consultancies, and pharmaceutical and healthcare brands to specialized healthcare audiences - physicians, key opinion leaders, allied healthcare professionals, payers, patients, and caregivers.
Konovo milestones
- November 2025
Konovo launched Survey Studio, an AI tool trained specifically on healthcare intelligence, designed to help researchers build a field-ready survey in real time while accounting for context, governance requirements, and research needs.
- February 2026
Konovo acquired Rare Patient Voice (RPV), a patient recruitment company founded in 2013 with over 200,000 registered patients and family caregivers across nine countries, adding patient-side recruitment for rare, chronic, and complex conditions alongside Konovo's existing healthcare professional reach.
FAQ
Konovo specializes in full-service healthcare market research - survey design, programming, fieldwork, and analysis - combining an AI-native research platform with the combined reach of its three founding brands.
No - Konovo is not part of the Inex One marketplace.
